|
EXPERT'S OPINION
|
|
FDA Response to COVID-19
|
A Discussion on Protocol Amendments and Clinical Study Reports in Affected Ongoing Trials.
Read More >>
|
|
|
BREAKING NEWS
|
|
AbbVie, I-Mab Enter Global Immuno-Oncology Alliance
|
AbbVie to pay as much as $1.74 billion for Lemzoparlimab, one of I-Mab's leading drug candidates for the treatment of multiple cancers.
Read More >>
|
|
|
|
|
Having Formulation Challenges?
|
Adare, the leader is taste-masking, utilizes the coacervation process to solve your formulation challenges from bitter tasting API’s to accelerating your development timelines.
Learn More >>
|
|
|
|
CNS Achieves Key Milestones in Berubicin Dual-track Mfg. Strategy
|
CNS and Pii complete successful lab simulation of the lyophilization cycle and Pii is expected to begin manufacturing Berubicin during 3Q20.
Read More >>
|
|
|
|
Catalent Invests $50M at Bloomington Facility
|
To install an additional high-speed vial filling line to support growing pipeline of clinical programs and commercial launches at the site.
Read More >>
|
|
|
|
|
|
Uhlmann Bottling Systems: IBC Family of Products
|
IBC family of products provide industry leading OEE as high as 95% with a space saving monoblock design.
Learn More >>
|
|
|
|
Gilead Sciences Signs Agreement with Jounce Therapeutics
|
Licenses Jounce’s JTX-1811, a monoclonal antibody targeting tumor-infiltrating T regulatory cells.
Read More >>
|
|
|
|
Stevanato Group, Nelson Labs Sign E&L Testing Pact
|
Partnership will provide Extractables and Leachables testing at SG US Technology Excellence Center in Boston.
Read More >>
|
|
|
|
|
|
World-Class Oncology Manufacturing
|
With over 60 years of oncology experience, BioPharma Solutions’ Halle, Germany facility is uniquely designed to deliver high-quality products with optimum efficiency and speed to market.
Learn More >>
|
|
|
|
Seqens Opens New HPAPI Unit
|
Will produce highly active ingredients at its Villeneuve-La-Garenne site.
Read More >>
|
|
|
|
PPD, Lupus Therapeutics to Support Lupus Clinical Research
|
To provide enhanced protocol and trial optimization capabilities for its customers leveraging LT’s scientific, operational and drug development expertise.
Read More >>
|
|
|
|
|
|
How to Control and Modify the Release of Today’s Insoluble, Potent APIs
|
Synchronizing and controlling API delivery, extrusion-spheronization is a robust technique offering pharmaceutical companies a reliable way to manufacture.
Learn More >>
|
|
|
|
Alcami, Trevana Enter Manufacturing Pact
|
Alcami to provide commercial manufacturing for recently FDA approved OLINVYK.
Read More >>
|
|
|
